Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by TD Private Client Wealth LLC

TD Private Client Wealth LLC cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,689 shares of the medical equipment provider’s stock after selling 529 shares during the quarter. TD Private Client Wealth LLC’s holdings in Intuitive Surgical were worth $1,812,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ridgewood Investments LLC bought a new position in Intuitive Surgical during the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. increased its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. LGT Financial Advisors LLC boosted its stake in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter worth $37,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Stock Up 0.2 %

Shares of Intuitive Surgical stock opened at $544.72 on Friday. The company’s fifty day simple moving average is $519.37 and its two-hundred day simple moving average is $477.06. Intuitive Surgical, Inc. has a 12-month low of $320.22 and a 12-month high of $556.23. The firm has a market cap of $194.02 billion, a PE ratio of 87.58, a price-to-earnings-growth ratio of 5.35 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Truist Financial raised their target price on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Finally, Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $550.28.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.